The procurement of methamphetamine for authorized research or therapeutic purposes presents particular challenges for institutions. Verifying compliance with federal statutes and stringent reporting necessities is necessarily critical. This process often involves precise record documentation, rigorous inventory controls, and consistent audits. Addi